Oxidative stress and vascular function

Cell Membranes and Free Radical Research

Volumn 5, Issue 1, 2013, Pages 221-232

  Daiber, Andreas ^a   Mader, Michael ^a   Stamm, Paul ^a   Zinßius, Elena ^a   Kröller Schön, Swenja ^a   Oelze, Matthias ^a   Münzel, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Mitochondria; NADPH oxidase; Nitric oxide synthase uncoupling; Oxidative stress; Peroxynitrite; Superoxide; Xanthine oxidase

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALDEHYDE DEHYDROGENASE ISOENZYME 2; APOCYNIN; ARGININE; ASCORBIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; NITROGEN DERIVATIVE; OXIDOREDUCTASE; PEROXYNITRITE; PROTEIN KINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TETRAHYDROBIOPTERIN; THIOL; TYROSINE; UNCOUPLING PROTEIN;

AGING; APOPTOSIS; BLOOD VESSEL FUNCTION; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CELL MEMBRANE; DNA STRAND BREAKAGE; ENDOTHELIAL DYSFUNCTION; ENZYME PHOSPHORYLATION; EXPERIMENTAL HYPERTENSION; FOREARM BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MITOCHONDRION; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RESPIRATORY CHAIN; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 84892401728     PISSN: 1308416X     EISSN: 13084178     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A, Goh N, Rockett KA and Channon KM. 2003. Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112: 725-735.
2. Antoniades C, Shirodaria C, Warrick N, Cai S, de Bono J, Lee J, Leeson P, Neubauer S, Ratnatunga C, Pillai R, Refsum H and Channon KM. 2006. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation 114: 1193-1201.
3. Berkenboom G, Fontaine D, Unger P, Baldassarre S, Preumont N and Fontaine J. 1999. Absence of nitrate tolerance after long-term treatment with ramipril: an endothelium- dependent mechanism. J Cardiovasc Pharmacol 34: 547-553.
4. Butler R, Morris AD, Belch JJ, Hill A and Struthers AD. 2000. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35: 746-751.
5. Cai S, Khoo J and Channon KM. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovasc Res 65: 823-831.
6. Daiber A, Oelze M, August M, Wendt M, Sydow K, Wieboldt H, Kleschyov AL and Munzel T. 2004. Detection of superoxide and peroxynitrite in model systems and mitochondria by the luminol analogue L-012. Free Radic Res 38: 259-269.
7. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG and Dikalov SI. 2010. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116.
8. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S and Griendling KK. 2010. Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 299: H673-679.
9. Doughan AK, Harrison DG and Dikalov SI. 2008. Molecular mechanisms of angiotensin II- mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102: 488-496.
10. Drexler H and Zeiher AM. 1991. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 18: II90-99.
11. Duffy SJ, Gokce N, Holbrook M, Hunter LM, Biegelsen ES, Huang A, Keaney JF, Jr. and Vita JA. 2001. Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 280: H528-534.
12. Forstermann U and Munzel T. 2006. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714.
13. Furchgott RF and Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
14. Gokce N, Keaney JF, Jr., Hunter LM, Watkins MT, Menzoian JO and Vita JA. 2002. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105: 1567-1572.
15. Gori T, Burstein JM, Ahmed S, Miner SE, Al-Hesayen A, Kelly S and Parker JD. 2001. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 104: 1119-1123.
16. Heitzer T, Brockhoff C, Mayer B, Warnholtz A, Mollnau H, Henne S, Meinertz T and Munzel T. 2000. Tetrahydrobiopterin improves endothelium- dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res 86: E36-41.
17. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschutter A and Meinertz T. 2001. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 31: 53-61.
18. Heitzer T, Just H, Brockhoff C, Meinertz T, Olschewski M and Munzel T. 1998. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstrictors in men with stable coronary artery disease: prevention by concomitant treatment with captopril. J Am Coll Cardiol 31: 83-88.
19. Heitzer T, Just H and Munzel T. 1996. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94: 6-9.
20. Heitzer T, Krohn K, Albers S and Meinertz T. 2000. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 43: 1435-1438.
21. Heitzer T, Schlinzig T, Krohn K, Meinertz T and Munzel T. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104: 2673-2678.
22. Heitzer T, Yla-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M and Drexler H. 1996. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93: 1346-1353.
23. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U and Munzel T. 2001. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus. Circ Res 88: E14-E22.
24. Hirai N, Kawano H, Yasue H, Shimomura H, Miyamoto S, Soejima H, Kajiwara I, Sakamoto T, Yoshimura M, Nakamura H, Yodoi J and Ogawa H. 2003. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation 108: 1446-1450.
25. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M and Abe Y. 2005. Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide. Hypertension 45: 438-444.
26. Kintscher U, Bramlage P, Paar WD, Thoenes M and Unger T. 2007. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Cardiovasc Diabetol 6: 12.
27. Knorr M, Hausding M, Kroller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A and Munzel T. 2011. Nitroglycerin-Induced Endothelial Dysfunction and Tolerance Involve Adverse Phosphorylation and S-Glutathionylation of Endothelial Nitric Oxide Synthase: Beneficial Effects of Therapy With the AT1 Receptor Blocker Telmisartan. Arterioscler Thromb Vasc Biol 31: 2223-2231.
28. Kroller-Schon S, Steven S, Kossmann S, Scholz A, Daub S, Oelze M, Xia N, Hausding M, Mikhed Y, Zinssius E, Mader M, Stamm P, Treiber N, Scharffetter-Kochanek K, Li H, Schulz E, Wenzel P, Munzel T and Daiber A. 2013. Molecular mechanisms of the crosstalk between mitochondria and NADPH oxidase through reactive oxygen species - studies in white blood cells and in animal models. Antioxid Redox Signal.
29. Kurz S, Hink U, Nickenig G, Borthayre AB, Harrison DG and Munzel T. 1999. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance. Circulation 99: 3181-3187.
30. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE and Harrison DG. 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209.
31. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T and Harrison DG. 2001. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288.
32. Liochev SI and Fridovich I. 1997. Lucigenin luminescence as a measure of intracellular superoxide dismutase activity in Escherichia coli. Proc Natl Acad Sci U S A 94: 2891-2896.
33. Mather KJ, Verma S and Anderson TJ. 2001. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37: 1344-1350.
34. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW and Hiatt WR. 2003. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 107: 753-756.
35. Mollnau H, Schulz E, Daiber A, Baldus S, Oelze M, August M, Wendt M, Walter U, Geiger C, Agrawal R, Kleschyov AL, Meinertz T and Munzel T. 2003. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 23: 615-621.
36. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K and Munzel T. 2002. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-65.
37. Munzel T, Daiber A, Ullrich V and Mulsch A. 2005. Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase. Arterioscler Thromb Vasc Biol 25: 1551- 1557.
38. Munzel T, Li H, Mollnau H, Hink U, Matheis E, Hartmann M, Oelze M, Skatchkov M, Warnholtz A, Duncker L, Meinertz T and Forstermann U. 2000. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res 86: E7-E12.
39. Munzel T, Mollnau H, Hartmann M, Geiger C, Oelze M, Warnholtz A, Yehia AH, Forstermann U and Meinertz T. 2000. Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production. J Am Coll Cardiol 36: 628- 634.
40. Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U and Munzel T. 2006. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension 48: 677-684.
41. Oelze M, Schuhmacher S and Daiber A. 2010. Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate. Exp Diabetes Res 2010: 213176.
42. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J and Pfeffer MA. 2009. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24: 1663-1671.
43. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P and Schillaci G. 2001. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104: 191-196.
44. Pitt B, Stier CT, Jr. and Rajagopalan S. 2003. Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 164-168.
45. Schuhmacher S, Wenzel P, Schulz E, Oelze M, Mang C, Kamuf J, Gori T, Jansen T, Knorr M, Karbach S, Hortmann M, Mathner F, Bhatnagar A, Forstermann U, Li H, Munzel T and Daiber A. 2010. Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1. Hypertension 55: 897-904.
46. Schulz E, Jansen T, Wenzel P, Daiber A and Munzel T. 2008. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115-1126.
47. Schulz E, Wenzel P, Munzel T and Daiber A. 2012. Mitochondrial redox signaling: interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal Epub ahead of print: doi:10.1089/ars.2012.4609.
48. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P and Creager MA. 1996. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97: 22-28.
49. Tzemos N, Lim PO and MacDonald TM. 2001. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 104: 511- 514.
50. Wang S, Xu J, Song P, Wu Y, Zhang J, Chul Choi H and Zou MH. 2008. Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 52: 484-490.
51. Warnholtz A, Ostad MA, Heitzer T, Thuneke F, Frohlich M, Tschentscher P, Schwedhelm E, Boger R, Meinertz T and Munzel T. 2007. AT1-receptor blockade with irbesartan improves peripheral but not coronary endothelial dysfunction in patients with stable coronary artery disease. Atherosclerosis 194: 439-445.
52. Watanabe H, Kakihana M, Ohtsuka S and Sugishita Y. 1998. Preventive effects of angiotensin-converting enzyme inhibitors on nitrate tolerance during continuous transdermal application of nitroglycerin in patients with chronic heart failure. Jpn Circ J 62: 353-358.
53. Wenzel P, Mollnau H, Oelze M, Schulz E, Wickramanayake JM, Muller J, Schuhmacher S, Hortmann M, Baldus S, Gori T, Brandes RP, Munzel T and Daiber A. 2008. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal 10: 1435-1447.
54. Wenzel P, Schulz E, Oelze M, Muller J, Schuhmacher S, Alhamdani MS, Debrezion J, Hortmann M, Reifenberg K, Fleming I, Munzel T and Daiber A. 2008. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med 45: 619-626.
55. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC and Creager MA. 1998. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97: 1695-1701.
56. Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, Munzel T, Forstermann U and Li H. 2010. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 335: 149-154.